Based on real-world data, Johnson & Johnson (NYSE:JNJ) announced Wednesday its prostate cancer therapy Erleada (apalutamide) ...
People with low- and intermediate-risk prostate cancer treated with either of two types of contemporary radiation ...
New Data Presented at ASTRO 2024 Show that Veracyte’s Decipher Prostate Test Predicts Aggressive Prostate Cancer in African American Men.
Research shows 69 per cent of Black adults are unaware that Black men face a two-fold increased risk of developing prostate ...
Ahmedabad: Zydus Lifesciences Limited has received tentative approval from the United States Food and Drug Administration ...
Prostate cancer is the most commonly diagnosed cancer in males in 118 of 185 countries, but it's the leading cause of death ...
New data show excellent quality-of-life outcomes and effective tumor control for both intensity-modulated radiation therapy ...
HOUSTON — September is Prostate Cancer Awareness Month. One in eight men will be diagnosed during their lifetime, and it's ...
Prostate cancer screening can help detect signs of cancer before symptoms start. It’s essential for men to talk with their ...